A Preliminary Study of Cytokine Gene Polymorphism Effects on Saudi Patients with Colorectal Cancer

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2020 Dec 9

PMID 33294886

Citations 4

Authors

Sarah A Althubyani

Afrah F Alkhuriji

Suliman Y Al Omar

Manal F El-Khadragy

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the possible associations of polymorphisms in interleukin (IL)-8 (rs4073 T/A), IL-10 (rs1800896 A/G), IL-22 (rs1179251 C/G and rs2227485 C/T), IL-27 (rs17855750 T/G), and transforming growth factor beta 1 (TGFß1) (rs1800469 C/T) with colorectal cancer (CRC) susceptibility in Saudi patients.

Methods: The case-control study was carried out between July 2019 and January 2020 in King Khaled University Hospital, Riyadh, Saudi Arabia. A total of 70 patients with CRC and 70 healthy controls were included in the study. Single nucleotide polymorphisms of promoter regions were determined using TaqMan genotyping assays.

Results: A statistically significant reduction in CRC risk was identified for carriers of the IL-10 (rs1800896 A/G) AG genotype, IL-22 (rs1179251 C/G) G allele, IL-27 (rs17855750 T/G) G allele and TGFß1 (rs1800469 C/T) CT and TT genotype. While IL-10 (rs1800896 A/G) AA genotype and TGFß1 (rs1800469 C/T) CC genotype were significantly associated with increased susceptibility to CRC. No significant associations were identified between the cytokine polymorphisms of IL-8 (rs4073 T/A) and IL-22 (rs2227485 C/T), and CRC risk. Conclusion: Our findings indicate a significant impact of IL-10 (rs1800896 A/G), IL-22 (rs1179251 C/G), IL-27 (rs17855750 T/G) and TGF-ß1 (rs1800469 C/T) polymorphisms on risk of CRC; while the IL-8 (rs4073 T/A) and IL-22 (rs2227485 C/T) and polymorphisms were not associated with CRC risk.

Citing Articles

Association between factor I fibrinogen (rs6050) and factor XI plasma thromboplastin (rs4253417) genetic polymorphisms and recurrent spontaneous miscarriage in Saudi women.

Kaabi A, Alkhuriji A, Babay Z, Barakat I, Kaabi A, Kaabi R Saudi Med J. 2025; 46(2):150-156.

PMID: 39933768 PMC: 11822937. DOI: 10.15537/smj.2025.46.2.20240692.

The Association Between IL-8 Gene Polymorphisms and the Risk of Several Types of Cancer, Especially in Gastric Cancer.

Xu B, Yan Y Cancer Rep (Hoboken). 2025; 8(1):e70103.

PMID: 39821721 PMC: 11740087. DOI: 10.1002/cnr2.70103.

A Meta-Analysis of Association Between Interleukin Polymorphisms (rs4073, rs1800925, rs1179251, rs1179246, rs2227485, rs17855750, and rs153109) and Colorectal Cancer Risk.

Sadafi S, Amirifard N, Aleagha O, Mirbahari S, Sadeghi M Biochem Genet. 2024; .

PMID: 39548028 DOI: 10.1007/s10528-024-10969-1.

The role of IL-22 in cancer.

Hunzeker Z, Zhao L, Kim A, Parker J, Zhu Z, Xiao H Med Oncol. 2024; 41(10):240.

PMID: 39231878 DOI: 10.1007/s12032-024-02481-8.

Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs.

Almutairi M, Alrubie T, Alshareeda A, Albarakati N, Almotiri A, Alamri A PLoS One. 2024; 19(8):e0307724.

PMID: 39208330 PMC: 11361649. DOI: 10.1371/journal.pone.0307724.

References

Gulubova M, Aleksandrova E, Vlaykova T . Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer. J Gene Med. 2018; 20(2-3):e3005. DOI: 10.1002/jgm.3005. View

Zhang J, Zhao T, Xu C, Yu H . Four polymorphisms in the IL-22 gene and the risk of cancer: A meta-analysis. J Evid Based Med. 2018; 11(2):101-104. DOI: 10.1111/jebm.12296. View

Chen Y, Zhong H, Gao J, Tang J, Wang R . A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update. Urol J. 2015; 12(3):2138-47. View

Yang Z, Chen Y, Wu D, Min Z, Quan Y . Analysis of risk factors for colon cancer progression. Onco Targets Ther. 2019; 12:3991-4000. PMC: 6535430. DOI: 10.2147/OTT.S207390. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Ghavami A, Fathpour G, Amirghofran Z . Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia. Pathol Oncol Res. 2017; 24(3):653-662. DOI: 10.1007/s12253-017-0295-2. View

Xu X, Hua L, Chao H, Chen Z, Wang X, Ji J . Genetic association between IL-27 rs153109 polymorphism and cancer risk in Chinese population: a meta-analysis. J Recept Signal Transduct Res. 2014; 37(4):335-340. DOI: 10.3109/10799893.2014.986743. View

Zhang M, Tan X, Huang J, Ke Z, Ge Y, Xiong H . Association of 3 Common Polymorphisms of IL-27 Gene with Susceptibility to Cancer in Chinese: Evidence From an Updated Meta-Analysis of 27 Studies. Med Sci Monit. 2015; 21:2505-13. PMC: 4554366. DOI: 10.12659/MSM.895032. View

Yang R, Zheng G, Ren D, Chen C, Zeng C, Lu W . The clinical significance and biological function of tropomyosin 4 in colon cancer. Biomed Pharmacother. 2018; 101:1-7. DOI: 10.1016/j.biopha.2018.01.166. View

10.

Lin L, Xu W, Zhang G, Ren P, Zhao J, Yan Q . Association of interleukin-22 polymorphisms with the colon cancer: A case-control study. Immunol Lett. 2017; 188:59-63. DOI: 10.1016/j.imlet.2017.06.007. View

11.

Shi J, Yuan M, Liu S, Duan X, Chen J . Correlation of IL-27 genetic polymorphisms with the risk and survival of cervical cancer in a Chinese Han population. Tumour Biol. 2015; 37(5):6875-9. DOI: 10.1007/s13277-015-4512-x. View

12.

Nie X, Yuan F, Chen P, Pu Y, Zhu J, Wang Y . Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma. Biomark Med. 2016; 11(2):141-149. DOI: 10.2217/bmm-2016-0283. View

13.

Stanilova S, Stanilov N, Julianov A, Manolova I, Miteva L . Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender. PLoS One. 2018; 13(8):e0201775. PMC: 6072135. DOI: 10.1371/journal.pone.0201775. View

14.

Mager L, Wasmer M, Rau T, Krebs P . Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol. 2016; 6:96. PMC: 4835502. DOI: 10.3389/fonc.2016.00096. View

15.

Qin S, Yang X, Luo W, Chen M, Liu Z, Su S . Association of interleukin 22 polymorphisms with gastric cancer risk. Tumour Biol. 2014; 36(3):2033-9. DOI: 10.1007/s13277-014-2810-3. View

16.

Testa U, Pelosi E, Castelli G . Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci (Basel). 2018; 6(2). PMC: 6024750. DOI: 10.3390/medsci6020031. View

17.

Yoshimoto T, Chiba Y, Furusawa J, Xu M, Tsunoda R, Higuchi K . Potential clinical application of interleukin-27 as an antitumor agent. Cancer Sci. 2015; 106(9):1103-10. PMC: 4582978. DOI: 10.1111/cas.12731. View

18.

Hargadon K . Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity. J Clin Med. 2016; 5(9). PMC: 5039479. DOI: 10.3390/jcm5090076. View

19.

Shi Y, Zhao D, Wang Y, Li X, Ji M, Jiang D . The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis. Sci Rep. 2016; 6:30809. PMC: 4973248. DOI: 10.1038/srep30809. View

20.

Alsanea N, Abduljabbar A, Alhomoud S, Ashari L, Hibbert D, Bazarbashi S . Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies. Ann Saudi Med. 2015; 35(3):196-202. PMC: 6074461. DOI: 10.5144/0256-4947.2015.196. View